|
Carol C. Grundfest joined Cell Genesys in 2003 as vice president, regulatory affairs and project management. Prior to joining Cell Genesys, Ms. Grundfest served as executive director of project management and strategic planning at Systemix, Inc. and Genetic Therapy, Inc. (affiliates of Novartis AG). Ms. Grundfest also held senior regulatory positions with Roche Global Development and Syntex, as well as served as assistant vice president, R&D at the Pharmaceutical Research and Manufacturers of America. Ms. Grundfest brought over 20 years of regulatory affairs and project management experience in the pharmaceutical industry. Ms. Grundfest received an M.H.S. in environmental health sciences from The Johns Hopkins University, School of Public Health and a B.S. in Biology from Stanford University. | 